Тhe Farmak delegation took part in the last conference and meeting of the ORBIS project in the city of Poznan, Poland. The project lasted 5 years as part of the…
The EMA has launched a consultation on the circumstances in which single-arm trials (SATs) – those without a control group – can be used to support marketing applications for medicines…